Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Merck & Co Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MRK
New York
2834
https://www.merck.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Merck & Co Inc
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
- Apr 25th, 2024 3:42 pm
20 Fastest Growing Health Tech Companies in the World
- Apr 25th, 2024 3:34 pm
Merck raises 2024 guidance on cancer drug demand
- Apr 25th, 2024 3:23 pm
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
- Apr 25th, 2024 1:13 pm
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
- Apr 25th, 2024 1:00 pm
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
- Apr 25th, 2024 11:04 am
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
- Apr 25th, 2024 10:33 am
Merck Announces First-Quarter 2024 Financial Results
- Apr 25th, 2024 10:30 am
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
- Apr 25th, 2024 10:30 am
Alphabet, Microsoft, Southwest earnings: What to watch
- Apr 24th, 2024 9:50 pm
4 Large Drug Stocks to Hold on to Amid Industry Challenges
- Apr 24th, 2024 2:09 pm
Here’s Why Merck & Co. (MRK) Outperformed in Q1
- Apr 23rd, 2024 11:49 am
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
- Apr 22nd, 2024 6:39 pm
10 Best Performing Biotech ETFs in 2024
- Apr 22nd, 2024 3:10 pm
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 78%
- Apr 21st, 2024 11:00 am
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy
- Apr 19th, 2024 11:04 am
13 Best Low Volatility Stocks to Buy According to Hedge Funds
- Apr 18th, 2024 8:27 pm
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
- Apr 17th, 2024 12:00 pm
Merck Insiders Sold US$15m Of Shares Suggesting Hesitancy
- Apr 17th, 2024 11:00 am
3 Dow Stocks to Buy Now: Q2 Edition
- Apr 16th, 2024 7:17 pm
Scroll